Kidney Neoplasms Clinical Trials
82 clinical trials for Kidney Neoplasms across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer — RECRUITING
- Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations — RECRUITING
- Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging — RECRUITING · PHASE2
- CD70-targeted immunoPET Imaging of Kidney Cancer — RECRUITING · PHASE2
- Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) — RECRUITING
- Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma — RECRUITING
- Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions — RECRUITING
- HTL0039732 in Participants With Advanced Solid Tumours — RECRUITING · PHASE1
- Planning Operative Strategy Using a Digital Renal Artery Clamping Tool — RECRUITING · NA
- Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage — RECRUITING · NA
- Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach — RECRUITING · NA
- Savolitinib vs. Sunitinib in MET-driven PRCC. — ACTIVE_NOT_RECRUITING · PHASE3
- Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell Carcinoma — ACTIVE_NOT_RECRUITING
- MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers — ACTIVE_NOT_RECRUITING · NA
- Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response — TERMINATED · NA
- The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer — COMPLETED
- The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy — COMPLETED · NA
- A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma — TERMINATED · PHASE1
- Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) — TERMINATED · PHASE2
- A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy — COMPLETED · PHASE1
- A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India — COMPLETED · PHASE4
- Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American — COMPLETED
- A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. — COMPLETED
- Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries — COMPLETED
- Tracking Renal Tumors After Cryoablation Evaluation — TERMINATED
- Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma — OTHER
- Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study — COMPLETED
- Cabozantinib for Advanced Urothelial Cancer — COMPLETED · PHASE2
- The Association of Marital Status With Kidney Cancer Surgery Morbidity — COMPLETED
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — COMPLETED · PHASE3
- IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) — COMPLETED
- Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma — OTHER · PHASE2
- Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients — OTHER · PHASE4
- The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy — TERMINATED · PHASE4
- LPN in Patients With High-complex Renal Tumors — COMPLETED
- Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors — OTHER
- Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors — COMPLETED · PHASE1
- Study of Nivolumab for Advanced Cancers in India — COMPLETED · PHASE4
- Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy — COMPLETED · NA
- A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma — TERMINATED · PHASE1
- 3D Virtual Models as an Adjunct to Preoperative Surgical Planning — COMPLETED
- Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. — WITHDRAWN · NA
- Von Hippel-Lindau Disease Genetic Epidemiology Study — TERMINATED
- Laparoscopic Partial Nephrectomy for cT1 Tumors — COMPLETED
- [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment — WITHDRAWN · PHASE1
- Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT — COMPLETED
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma — COMPLETED
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice — TERMINATED
- Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — COMPLETED · PHASE3
- The Effect of Pre-treatment Biopsy for Non-neoplastic Renal Disease vs no Biopsy on Estimated Glomerular Filtration Rate in Patients With Small Renal Mass: a Single-center, Single-blinded, Randomized, Parallel Group Clinical Trial — WITHDRAWN · NA
Refine this search